| Record ID | harvard_bibliographic_metadata/ab.bib.09.20150123.full.mrc:362175262:1062 |
| Source | harvard_bibliographic_metadata |
| Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.09.20150123.full.mrc:362175262:1062?format=raw |
LEADER: 01062nam a2200289 a 4500
001 009358091-6
005 20060606151455.0
008 040510s2003 cau b 000|0 eng d
040 $aMH-L$cMH-L
043 $an-us---
050 4 $aKF3133.B56$bD46x 2003
100 1 $aDemaine, Linda J.
245 10 $aReinventing the double helix :$ba novel and nonobvious reconceptualization of the biotechnology patent /$cLinda J. Demaine, Aaron Xavier Fellmeth.
260 $aSanta Monica, CA :$bRAND,$c2003.
300 $ap. 303-462 ;$c28 cm.
490 1 $aReprint ;$vRP-1049
500 $aAt head of title: RAND Law & Health.
500 $a"Reprinted by permission from Stanford Law Review, November 2002, Vol. 55, pp. 303-462."
504 $aIncludes bibliographical references.
650 0 $aBiotechnology$zUnited States$xPatents.
650 0 $aPatent laws and legislation$zUnited States.
700 1 $aFellmeth, Aaron Xavier.
710 2 $aRand Corporation.
730 0 $aStanford law review.
830 0 $aRand reprints ;$vRP-1049.
988 $a20040510
906 $0MH